Rapafusyn Pharmaceuticals-preview

Rapafusyn

Rapafusyn Pharmaceuticals

Private

Baltimore, MarylandHealthcare & Life Scienceshttps://rapafusyn.com

Last Round

Series A

Sep 4, 2025

Total Funding Raised

$44M

Momentum Score

50 /100

Company Overview

Rapafusyn Pharmaceuticals is a drug discovery company that develops non-degrading molecular glues (RapaGlues™) to address challenging therapeutic targets.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

molecular gluesdrug discovery platformtargeted protein degradationTPDundruggable targetsprotein degradationrational drug designpreclinical biotechmacrocyclesDNA-encoded librariesDELprotein-protein interactionpharma licensingLRRK2 inhibitormTORC1 inhibitormachine learning drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rapafusyn Pharmaceuticals Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Rapafusyn Pharmaceuticals Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Sep 4, 2025

View all Funding Rounds

Key People

Founding team and executive leadership

Sean X. Hu

President And CEO

Executive Team

Rapafusyn Pharmaceuticals Investors

Notable investors and investment history

Investor	Rounds
BioTrack Capital	Series A
Bencao Capital	Series A
Yonjin Capital	Series A
Lapam Capital	Series A
Proxima Ventures Ltd.	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Sep 4, 2025
$44M round completed.
Jan 14, 2025
Hosting executive roundtable at WuXi Global Forum on Jan 14, 2025.

View all signals

Rapafusyn Pharmaceuticals Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Rapafusyn Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Rapafusyn Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersBaltimore, Maryland

Employee Range20

Year Founded2015

Last FundingSep 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.